Vildagliptin
From Proteopedia
(Difference between revisions)
(New page: <applet load="" size="480" color="" frame="true" spin="on" Scene ="" align="right" caption="Vildagliptin, better known as ____, (___)"/> ===Better Known as: === * Marketed By: * Maj...) |
|||
| Line 1: | Line 1: | ||
| - | <applet load="" size="480" color="" frame="true" spin="on" Scene ="" align="right" caption="Vildagliptin, better known as | + | <applet load="" size="480" color="" frame="true" spin="on" Scene ="" align="right" caption="Vildagliptin, better known as Galvus, ([[___]])"/> |
| - | ===Better Known as: === | + | ===Better Known as: Galvus=== |
* Marketed By: | * Marketed By: | ||
* Major Indication: | * Major Indication: | ||
Revision as of 09:33, 13 December 2010
|
Better Known as: Galvus
- Marketed By:
- Major Indication:
- Drug Class:
- Date of FDA Approval (Patent Expiration):
- 2009 Sales:
- Importance:
- See Pharmaceutical Drugs for more information about other drugs and diseases.
Mechanism of Action
Pharmacokinetics
For Pharmacokinetic Data References, see: References |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
References
